This is true. However the FDA is a very slow regulatory body. Quite frequently in the pharmaceutical industry deadlines are shifted a month or two past when originally expected.
I looked at the recent powerpoint (Link below)and was very impressed. INNV seems to be turning cash flow positive and is expecting several product launches in the coming months.
They have also signed an agreement with a manufacturer for Fluticare. This is a serious undertaking and would not be done unless the CEO was confident in approval.
All I know is I don't want to be left on the sidelines if news drops in the next few weeks.
ALL IMO. GLTA Here.
+Everything I say is IMO. Do your own DD. Stay sharp.+ Penny